Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 7
2007 1
2008 6
2009 7
2010 8
2011 9
2012 14
2013 11
2014 17
2015 11
2016 12
2017 25
2018 32
2019 21
2020 48
2021 67
2022 55
2023 24
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Results by year

Filters applied: . Clear all
Page 1
Diabetes and lipid metabolism.
Athyros VG, Doumas M, Imprialos KP, Stavropoulos K, Georgianou E, Katsimardou A, Karagiannis A. Athyros VG, et al. Among authors: doumas m. Hormones (Athens). 2018 Mar;17(1):61-67. doi: 10.1007/s42000-018-0014-8. Epub 2018 Apr 16. Hormones (Athens). 2018. PMID: 29858856 Review.
Pharmacological Management of Type 2 Diabetes Complications.
Doumas M, Imprialos K, Stavropoulos K, Athyros VG. Doumas M, et al. Curr Vasc Pharmacol. 2020;18(2):101-103. doi: 10.2174/157016111802200101155519. Curr Vasc Pharmacol. 2020. PMID: 32013814 No abstract available.
Primary Aldosteronism: Novel Insights.
Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, Doumas M. Stavropoulos K, et al. Among authors: doumas m. Curr Hypertens Rev. 2020;16(1):19-23. doi: 10.2174/1573402115666190415155512. Curr Hypertens Rev. 2020. PMID: 30987572 Review.
Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.
Stavropoulos K, Papadopoulos C, Koutsampasopoulos K, Lales G, Mitas C, Doumas M. Stavropoulos K, et al. Among authors: doumas m. Curr Pharm Des. 2018;24(46):5508-5516. doi: 10.2174/1381612825666190311130138. Curr Pharm Des. 2018. PMID: 30854950 Review.
Dysmetabolic Iron Overload in Metabolic Syndrome.
Sachinidis A, Doumas M, Imprialos K, Stavropoulos K, Katsimardou A, Athyros VG. Sachinidis A, et al. Among authors: doumas m. Curr Pharm Des. 2020;26(10):1019-1024. doi: 10.2174/1381612826666200130090703. Curr Pharm Des. 2020. PMID: 32000639 Review.
PDE-5 inhibitors: clinical points.
Doumas M, Lazaridis A, Katsiki N, Athyros V. Doumas M, et al. Curr Drug Targets. 2015;16(5):420-6. doi: 10.2174/1389450115666141111111301. Curr Drug Targets. 2015. PMID: 25392015 Review.
Impact of Primary Aldosteronism in Resistant Hypertension.
Stavropoulos K, Imprialos KP, Patoulias D, Katsimardou A, Doumas M. Stavropoulos K, et al. Among authors: doumas m. Curr Hypertens Rep. 2022 Aug;24(8):285-294. doi: 10.1007/s11906-022-01190-9. Epub 2022 Apr 21. Curr Hypertens Rep. 2022. PMID: 35445928 Review.
331 results